<bill session="116" type="h" number="2115" updated="2019-11-01T04:58:41Z">
  <state datetime="2019-10-28T19:18:16-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2019-10-28T19:18:16-04:00"/>
  </status>
  <introduced datetime="2019-04-08"/>
  <titles>
    <title type="short" as="introduced">Public Disclosure of Drug Discounts Act</title>
    <title type="short" as="introduced">Public Disclosure of Drug Discounts Act</title>
    <title type="short" as="passed house">Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act</title>
    <title type="short" as="passed house">Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act</title>
    <title type="official" as="introduced">To amend title XI of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers.</title>
    <title type="official" as="amended by house">To amend titles XI and XVIII of the Social Security Act to provide greater transparency for discounts provided by manufacturers, to include real-time benefit information as part of a prescription drug plan's electronic prescription program under the Medicare program, and for other purposes.</title>
    <title type="display">Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act</title>
  </titles>
  <sponsor bioguide_id="S001209"/>
  <cosponsors>
    <cosponsor bioguide_id="A000375" joined="2019-04-08"/>
    <cosponsor bioguide_id="B001296" joined="2019-04-08"/>
    <cosponsor bioguide_id="S001208" joined="2019-10-28"/>
    <cosponsor bioguide_id="T000479" joined="2019-10-28"/>
    <cosponsor bioguide_id="V000133" joined="2019-05-01"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-08">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-08" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-08">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-04-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-04-09">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-05-21">
      <text>Subcommittee Hearings Held.</text>
    </action>
    <action datetime="2019-10-28T18:19:35-04:00">
      <text>Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2019-10-28T18:19:39-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H8516-8519" label="consideration"/>
    </action>
    <action datetime="2019-10-28T18:19:41-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 2115.</text>
    </action>
    <action datetime="2019-10-28T18:40:10-04:00">
      <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
    </action>
    <action datetime="2019-10-28T19:09:04-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H8520-8521" label="consideration"/>
    </action>
    <vote how="roll" type="vote" roll="586" datetime="2019-10-28T19:18:16-04:00" where="h" result="pass" suspension="1" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586).</text>
      <reference ref="CR H8516" label="text"/>
    </vote>
    <action datetime="2019-10-28T19:18:17-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2019-10-28T19:18:20-04:00">
      <text>The title of the measure was amended. Agreed to without objection.</text>
    </action>
    <action datetime="2019-10-29">
      <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Hearings, Referral"/>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="3415"/>
    <bill type="h" session="116" relation="unknown" number="3408"/>
    <bill type="h" session="116" relation="unknown" number="2296"/>
    <bill type="h" session="116" relation="unknown" number="2113"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2019-04-08T04:00:00Z" status="Introduced in House">Public Disclosure of Drug Discounts Act

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.</summary>
  <committee-reports/>
</bill>
